GLP-1 Receptor Agonists - Good for Body Weight, Bad for Micronutrient Status?

Kerlikowsky, Felix et al.·Current developments in nutrition·2025·
RPEP-117812025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
GLP-1 Receptor Agonists - Good for Body Weight, Bad for Micronutrient Status?
Published In:
Current developments in nutrition, 9(11), 107587 (2025)
Database ID:
RPEP-11781

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11781·https://rethinkpeptides.com/research/RPEP-11781

APA

Kerlikowsky, Felix; Krämer, Klaus; Eggersdorfer, Manfred; Hahn, Andreas. (2025). GLP-1 Receptor Agonists - Good for Body Weight, Bad for Micronutrient Status?. Current developments in nutrition, 9(11), 107587. https://doi.org/10.1016/j.cdnut.2025.107587

MLA

Kerlikowsky, Felix, et al. "GLP-1 Receptor Agonists - Good for Body Weight, Bad for Micronutrient Status?." Current developments in nutrition, 2025. https://doi.org/10.1016/j.cdnut.2025.107587

RethinkPeptides

RethinkPeptides Research Database. "GLP-1 Receptor Agonists - Good for Body Weight, Bad for Micr..." RPEP-11781. Retrieved from https://rethinkpeptides.com/research/kerlikowsky-2025-glp1-receptor-agonists-good

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.